Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.

Acta neurologica Scandinavica - 1 Mar 2009

Wroolie T E, Kenna H A, Williams K E, Powers B N, Holcomb M, Lazzeroni L, Rasgon N L

Abstract excerpt

BACKGROUND: To determine the effects of memantine on cognition in a normal population of postmenopausal women with putative risk factors for Alzheimer's disease (AD) using a built-in control for the genetic risk factor for AD (apoE-epsilon4 status). METHODS: A prospective, open-label, 6-month pil...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition
Share to Dementia
Share to Excitatory Amino Acid Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypothyroidism

Share to Memory Disorders

Share to Mood Disorders

Share to Pilot Projects

Share to Postmenopause

Source

Identifiers

PMID: 18705678
DOI: 10.1111/j.1600-0404.2008.01084.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18705678-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.PMID 18705678Read ↗

Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.Semantic proximity Read ↗

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.Semantic proximity Read ↗

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.Semantic proximity Read ↗

Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.Semantic proximity Read ↗

Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's diseaseSemantic proximity Read ↗

Hormone Replacement Therapy is associated with improved cognition and larger brain volumes in at risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohortSemantic proximity Read ↗

Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.Semantic proximity Read ↗

Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.Semantic proximity Read ↗

Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.Semantic proximity Read ↗

Cognitive function in nondemented older women who took estrogen after menopause.Semantic proximity Read ↗

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.Semantic proximity Read ↗

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.